With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...
After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...
InvestorsHub on MSN
Aldeyra receives FDA rejection for dry eye treatment reproxalap
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...
Anyone who suffers from chronic dry eye knows that finding a competent dry eye doctor to help with symptoms is critical. Dry eyes develop as people age, plus the issue is often made worse by increased ...
Christine L. Larsen, MD, is an ophthalmologist practicing at Minnesota Eye Consultants where she serves as medical director for the four ancillary surgery centers in the practice. Infections, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results